Finance

Lists
688319:SHA
Chengdu Olymvax Biopharmaceuticals Inc
26,26 CNY
+1,90%
(+0,49) 1D
16 ოქტ, 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688319...
Open
26,37 CNY
High
27,48 CNY
Low
26,00 CNY
Mkt. cap
10,65 მლრდ.
Avg. vol.
6,17 მლნ.
Volume
4,40 მლნ.
52-wk high
44,90 CNY
52-wk low
20,41 CNY
EPS
-0,06 CNY
No. of employees
436
Open
26,37 CNY
High
27,48 CNY
Low
26,00 CNY
Mkt. cap
10,65 მლრდ.
Avg. vol.
6,17 მლნ.
Volume
4,40 მლნ.
52-wk high
44,90 CNY
52-wk low
20,41 CNY
EPS
-0,06 CNY
No. of employees
436
News stories
From web sources and news partners
About Chengdu Olymvax Biopharmaceuticals Inc
CEO-
Employees436
Founded11 დეკ. 2009
Headquarters-
Sector-
Websiteolymvax.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
201,07 მლნ.
197,24 მლნ.
157,80 მლნ.
203,52 მლნ.
Cost of goods sold
14,60 მლნ.
28,17 მლნ.
12,87 მლნ.
12,68 მლნ.
Cost of revenue
14,60 მლნ.
28,17 მლნ.
12,87 მლნ.
12,68 მლნ.
Research and development expenses
36,10 მლნ.
38,02 მლნ.
20,19 მლნ.
29,49 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
118,36 მლნ.
159,56 მლნ.
96,59 მლნ.
120,29 მლნ.
Operating expense
139,35 მლნ.
197,40 მლნ.
118,09 მლნ.
161,08 მლნ.
Total operating expenses
153,95 მლნ.
225,57 მლნ.
130,97 მლნ.
173,77 მლნ.
Operating income
47,12 მლნ.
-28,33 მლნ.
26,84 მლნ.
29,75 მლნ.
Other non operating income
-471,53 ათ.
365,44 ათ.
-173,54 ათ.
148,37 ათ.
EBT including unusual items
41,07 მლნ.
-23,86 მლნ.
32,42 მლნ.
-6,24 მლნ.
EBT excluding unusual items
43,58 მლნ.
-31,86 მლნ.
22,75 მლნ.
25,47 მლნ.
Income tax expense
7,15 მლნ.
1,39 მლნ.
5,22 მლნ.
53,84 მლნ.
Effective tax rate
17,41%
-5,84%
16,11%
-863,09%
Other operating expenses
828,21 ათ.
2,75 მლნ.
2,61 მლნ.
3,56 მლნ.
Net income
34,28 მლნ.
-25,22 მლნ.
27,19 მლნ.
-60,06 მლნ.
Net profit margin
17,05%
-12,79%
17,23%
-29,51%
Earnings per share
-
-
-
-
Interest and investment income
235,35 ათ.
290,12 ათ.
205,06 ათ.
98,07 ათ.
Interest expense
-3,30 მლნ.
-4,17 მლნ.
-4,12 მლნ.
-4,47 მლნ.
Net interest expenses
-3,07 მლნ.
-3,88 მლნ.
-3,92 მლნ.
-4,37 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
54,11 მლნ.
-19,96 მლნ.
35,20 მლნ.
39,45 მლნ.
Gain or loss from assets sale
8,71 ათ.
-8,71 ათ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები